PRIVATE PLACEMENT MEMORANDUM — CONFIDENTIAL.  This document is for accredited investors only under Rule 506(c). Not an offer to sell in any jurisdiction where prohibited. All figures based on RC3 conservative baseline assumptions.
Private Placement Memorandum · Rule 506(c) · Regulation D
Carbotura Inc.
Series A-1 Preferred Stock
Non-participating preferred stock offering in Carbotura Inc., a Delaware C-Corporation developing the first commercial-scale Advanced Circular Manufacturing platform. Proceeds fund construction and commissioning of the 400 TPD Regenesis Center in York County, Pennsylvania.
Series A-1 Non-Participating 1× Liquidation Preference 506(c) Reg D Delaware C-Corp
Issuer
Carbotura Inc.
DCF Enterprise Value
$286M
Project IRR
46%
Structure
Preferred Stock · Series A-1
Revenue Baseline
RevCon 3 (Conservative)
WACC (Discount Rate)
17% (Punitive)
Facility
York County, Pennsylvania
Capacity
400 TPD
Regulation
Rule 506(c) · Reg D
This PPM has been prepared for informational purposes and does not constitute legal or financial advice. All projections are forward-looking statements. Prospective investors should consult independent legal and financial advisors before making any investment decision. Requires review by securities counsel before distribution.
PPM Sections
ℹ The PPM is being finalized and will be available for review here. Sections marked as Available can be reviewed now. Contact Shannon Law to schedule a walk-through with Paul Camp.
I
Cover Page & Summary of Terms
6 pp
Available
II
Risk Factors
18 pp
Available
III
Business Description — Advanced Circular Manufacturing
24 pp
Available
IV
Technology — The Regenesis Protocol
20 pp
Available
V
Financial Projections — RC3 Baseline
32 pp
In Review
VI
Use of Proceeds
—
Pending
VII
Capitalization & Cap Table
—
Pending
VIII
Terms of the Offering
—
Pending
IX
Subscription Agreement
—
Pending
X
Exhibits — COA, Technical Schedules, IE Letter
—
Pending
📅
Schedule Structural Review
Walk through the PPM with Paul Camp (EVP Capital Markets). He will address your specific questions on structure, terms, and use of proceeds.
Request Review →
💬
Investor Q&A
Submit questions directly to Shannon Law (EVP Investor Relations). Written responses will be added to the investor FAQ within the data room.
Submit Question
📋
Subscribe
When you are ready to proceed, execute the Subscription Agreement here. DocuSign integration pending — contact Shannon Law to begin subscription.
Begin Subscription →